Our long-term analysis of semaglutide in a large and diverse cohort of patients with type 2 diabetes found a clinically relevant improvement in blood sugar control and weight loss after 6 months of treatment, comparable with that seen in randomised trials, said investigator Avraham Karasik, MD, lead author and professor at the Institute of Research and Innovation at Maccabi Health Services in Israel, the second largest health maintenance organization in the country
HFpEF is notoriously difficult to treat, and currently, only two drugs, the SGLT2 inhibitors dapagliflozin and empagliflozin, are FDA-approved to treat it
Definitely have seen weight loss as well Ive been using this and the skinny shot off and on for a while now
Liver-metabolized medications deplete heme iron, reducing oxygen and nutrients to other organs
To view or add a comment, sign in Compelling observation from this case series: once weight loss is achieved, lower GLP-1 exposure may be sufficient for maintenance